Drug interactions between eltrombopag and Sulfatrim
Interactions between your drugs
There were no interactions found in our database between eltrombopag and Sulfatrim - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Eltrombopag is in the drug class platelet-stimulating agents.
- Eltrombopag is used to treat the following conditions:
- Sulfatrim is a member of the drug class sulfonamides.
- Sulfatrim is used to treat the following conditions:
- Bacterial Infection
- Bacterial Skin Infection
- Granuloma Inguinale
- Infection Prophylaxis
- Kidney Infections
- Otitis Media
- Pneumocystis Pneumonia
- Pneumocystis Pneumonia Prophylaxis
- Prevention of Bladder infection
- Toxoplasmosis, Prophylaxis
- Traveler's Diarrhea
- Upper Respiratory Tract Infection
- Urinary Tract Infection
Drug and food interactions
Applies to: eltrombopag
Food may reduce the absorption and blood levels of eltrombopag. In addition, minerals such as aluminum, calcium, iron, magnesium, and zinc can also interfere with eltrombopag absorption into the bloodstream, which may make the medication less effective in treating your condition. You should take eltrombopag on an empty stomach one hour before or two hours after a meal. Eltrombopag should also be taken at least 2 hours before or 4 hours after products like antacids, mineral supplements, dairy products, and fortified juices. Talk to your doctor or pharmacist if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.